IRIS
FABRIS, Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.454
AS - Asia 4.722
EU - Europa 3.227
SA - Sud America 854
AF - Africa 121
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.282
SG - Singapore 2.188
CN - Cina 915
BR - Brasile 660
IT - Italia 654
UA - Ucraina 629
HK - Hong Kong 477
DE - Germania 467
VN - Vietnam 424
FI - Finlandia 290
RU - Federazione Russa 275
FR - Francia 233
IN - India 178
GB - Regno Unito 162
IE - Irlanda 157
SE - Svezia 114
TR - Turchia 102
CA - Canada 86
BD - Bangladesh 69
AR - Argentina 60
KR - Corea 55
MX - Messico 51
AT - Austria 42
IQ - Iraq 42
ZA - Sudafrica 42
JP - Giappone 40
ES - Italia 36
ID - Indonesia 35
EC - Ecuador 34
NL - Olanda 34
PL - Polonia 29
BE - Belgio 27
SA - Arabia Saudita 24
PK - Pakistan 23
IR - Iran 22
CO - Colombia 21
PY - Paraguay 21
PH - Filippine 20
VE - Venezuela 17
CL - Cile 16
MA - Marocco 16
EG - Egitto 13
AZ - Azerbaigian 12
TG - Togo 11
UZ - Uzbekistan 11
AU - Australia 10
LT - Lituania 10
IL - Israele 9
PE - Perù 9
RS - Serbia 9
TN - Tunisia 9
DO - Repubblica Dominicana 8
JM - Giamaica 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
BY - Bielorussia 7
KZ - Kazakistan 7
NP - Nepal 7
RO - Romania 7
UY - Uruguay 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
KG - Kirghizistan 6
OM - Oman 6
AL - Albania 5
DZ - Algeria 5
KE - Kenya 5
LB - Libano 5
AM - Armenia 4
CR - Costa Rica 4
EE - Estonia 4
ET - Etiopia 4
EU - Europa 4
HU - Ungheria 4
JO - Giordania 4
PA - Panama 4
TH - Thailandia 4
BG - Bulgaria 3
HN - Honduras 3
HR - Croazia 3
KH - Cambogia 3
PS - Palestinian Territory 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
DK - Danimarca 2
LV - Lettonia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
DM - Dominica 1
GE - Georgia 1
Totale 18.371
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.008
Singapore 961
Ann Arbor 768
Ashburn 763
Chandler 657
Fairfield 654
Houston 533
Beijing 482
Hong Kong 469
Jacksonville 437
Wilmington 316
San Jose 292
Dearborn 287
Seattle 265
Boardman 204
Cambridge 200
Udine 163
Lauterbourg 155
Dublin 151
Princeton 145
Los Angeles 144
Ho Chi Minh City 123
Dallas 115
Council Bluffs 102
Helsinki 94
Munich 79
Izmir 77
Hanoi 75
Dong Ket 70
Redondo Beach 64
The Dalles 63
Hefei 62
New York 61
São Paulo 60
Buffalo 59
San Diego 59
Trieste 58
Redmond 56
Seoul 48
Santa Clara 40
Frankfurt am Main 38
Orem 37
Norwalk 36
Ogden 36
Montreal 35
Venezia 35
Tokyo 33
Nuremberg 31
Milan 29
Des Moines 26
Mumbai 26
Nanjing 26
Warsaw 26
Brussels 25
Guangzhou 25
Johannesburg 25
Denver 24
Belluno 23
Ottawa 23
Chennai 22
Düsseldorf 22
Amsterdam 21
Chicago 21
London 21
Rio de Janeiro 21
San Mateo 21
Phoenix 20
Belo Horizonte 19
Mexico City 19
Stockholm 19
Poplar 18
Baghdad 17
Leawood 17
Vienna 17
Atlanta 16
Boston 15
Da Nang 15
Augusta 14
Kunming 14
Lappeenranta 14
Rome 14
Toronto 14
Brooklyn 13
Grafing 13
New Delhi 13
Querétaro 13
Turku 13
Paris 12
Salvador 12
San Francisco 12
Baku 11
Codroipo 11
Guayaquil 11
Jeddah 11
Lomé 11
Tavagnacco 11
Curitiba 10
Miami 10
Ribeirão Preto 10
Shanghai 10
Totale 11.596
Salva come PNG Salva come JPEG
Nome #
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis 278
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 277
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes 237
Twist is substrate for caspase cleavage and proteasome-mediated degradation 210
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 206
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 195
Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients 190
Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients 187
Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients 185
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells 180
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 179
Cardiovascular Complications of Acromegaly. 172
Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine Tumors 171
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 167
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 165
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 161
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! 158
The role of B-lymphocyte stimulator in neuroendocrine tumors: Correlation with tumor differentiation, disease status and the presence of metastases 156
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 155
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 154
Anti-vimentin/cardiolipin complex autoantibodies in antiphospholipid syndrome: preliminary data using a new ELISA method. 151
BLyS and April serum levels in patients with autoimmune thyroid diseases. 150
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 150
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 150
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis. 147
Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review 144
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 143
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 143
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 141
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation 141
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 140
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 140
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 139
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 136
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 136
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 135
Epidemiology of paraneoplastic neurological syndromes: a population-based study 134
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. 131
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 130
Do circulating exosomes interfere with vedolizumab efficacy in IBD patients? 130
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 130
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 129
B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Disease Behavior 125
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease 124
HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations 123
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 123
-238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS 122
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 122
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 120
Comparison between Anti-β2Glycoprotein I Antibody and Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on Peripheral Blood Monocytes 120
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 119
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 119
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 118
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 118
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 118
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 117
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 117
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . 116
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 115
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 115
Characterization of Parotid Gland Epithelial Cell Primary Cultures from Patients Affected by Sjogren’s Syndrome 115
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 114
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report 114
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 114
Chlamydophila psittaci subclinical infection in chronic polyarthritis 114
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 113
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 111
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 111
Non-malignant lymphoproliferation in Sjögren’s syndrome: proposed classification based on integrated clinico-pathologic and molecular studies and follow-up. 110
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 110
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 109
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor 108
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 108
Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? 108
TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results 107
Rankl and osteoprotegerin serum levels changes after rituximab therapy in rheumatoid arthritis: correlation with disease control and bone mineral density preservation 107
Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis. 106
Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes 106
An overview on advantages and limitations of serological assays for saRs-coV-2 infectious disease 105
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 105
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 104
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 104
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 103
A Multiparametric Method Improves the Serological Characterization of Inflammatory Bowel Diseases: Preliminary Results from a Multicenter Eastern Europe Study 102
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 102
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. 102
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 102
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 101
Italy association of transforming growth factor-b (tgf-b) 869cc polymorphism with bone erosions in rheumatoid arthritis: an ultrasonographic study. 101
Evidence for an association between the -871 t/c promoter polymorphism in the b-lymphocyte stimulator (blys) gene and the development of an overt lymphoproliferative disorder in mixed cryoglobulinemia syndrome (mcsn) 100
Controversies on rituximab therapy in Sjögren's syndrome-associated lymphoproliferation 100
BlYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Factor, , vol 60 suppl 10 :1678 100
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? 99
B-Lymphocyte Stimulator in neuroendocrine tumors: correlation with disease behaviour. 99
Preliminary classification of nonmalignant B cell proliferation in Sjögren’s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells, Molecules and Diseases 2001; 27: 757-66 (IF 1.703) 99
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 99
Extracellular vesicle features are associated with COVID-19 severity 98
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 98
Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab 98
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents. 97
Totale 13.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021403 0 0 0 0 0 0 0 0 0 54 232 117
2021/20221.147 62 122 35 94 51 29 44 62 13 176 280 179
2022/20231.542 167 116 9 234 126 382 23 136 206 18 65 60
2023/2024499 73 37 24 15 75 62 13 54 58 46 12 30
2024/20253.244 83 213 228 136 118 142 233 196 354 276 495 770
2025/20265.591 531 572 510 780 860 533 692 192 529 392 0 0
Totale 18.773